Company / Capital Expenditures
Indivior Capital Expenditures History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$66.0M
FY2025
5-year range
$5.0M / $66.0M
FY2022-FY2025
Trend
+127.6%
vs FY2024
Sector context
#24 of 194
Health Care
What the data says
Indivior's capital expenditures of $66M is higher than 88% of companies in the Health Care sector (FY2025). Capital Expenditures has increased for 3 consecutive years, from $5M in FY2022 to $66M in FY2025.
Based on SEC 10-K filings.
$66M in FY2025 with a 3-year CAGR of +136.3%. Top quartile in the Health Care sector.
Improved from $8M to $66M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +136.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 194This company $66.0M Sector average $117.5M
▼
-43.8% below sector average
Key checks
Key Insights
- Indivior's capital expenditures has grown for 3 consecutive years.
- 3-year CAGR of +136.3%, indicating consistent growth.
- In FY2025, capital expenditures increased 127.6% year-over-year.
- Ranks #24 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $66.0M | +127.6% |
| FY2024 | $29.0M | +262.5% |
| FY2023 | $8.0M | +60.0% |
| FY2022 | $5.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026